Literature DB >> 15060434

Impact of intrapeptide epitope location on CD8 T cell recognition: implications for design of overlapping peptide panels.

Rika Draenert1, Christian Brander, Xu G Yu, Marcus Altfeld, Cori L Verrill, Margeret E Feeney, Bruce D Walker, Philip J R Goulder.   

Abstract

BACKGROUND: Antigen-specific CD8 T cells following infection or immunization are typically assessed by measuring interferon-gamma production after stimulation with overlapping peptides spanning the region of interest. The effect of epitope location within such peptides is not known but may influence recognition.
OBJECTIVE: To examine if peptides containing the appropriate C-terminal anchor amino acid residue would provide more sensitive detection of T cell responses. The impact was examined of epitope location within overlapping peptides on recognition of epitope-specific CD8 T cell responses.
METHODS: C-terminal amino acid residues were analyzed in well-defined optimal epitopes for HIV, Epstein-Barr virus, cytomegalovirus and influenza and in peptide-binding motifs. Recognition of known epitopes within longer synthesized peptides by peripheral blood mononuclear cells or CD8 T cell lines was tested using interferon-gamma Elispot at various peptide concentrations.
RESULTS: Only 9 of 20 amino acids served as the C-terminal anchor position in 96% of described optimal epitopes and in 95% of peptide-binding motifs. A CD8 T cell response to an epitope within a longer peptide is best detected when the epitope is situated at the C-terminal end of the longer peptide, both when using peptides designed to include the optimal epitope at every possible position and when comparing responses towards optimal epitopes and corresponding overlapping peptides in a larger group of subjects.
CONCLUSION: When using overlapping peptides to screen for CD8 T cell responses, more sensitive detection will be achieved using known C-terminal anchor amino acid residues at the C-terminus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15060434     DOI: 10.1097/00002030-200404090-00004

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  20 in total

1.  Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen.

Authors:  Asli Bauer; Lilli Podola; Philipp Mann; Marco Missanga; Antelmo Haule; Lwitiho Sudi; Charlotta Nilsson; Bahati Kaluwa; Cornelia Lueer; Maria Mwakatima; Patricia J Munseri; Leonard Maboko; Merlin L Robb; Sodsai Tovanabutra; Gustavo Kijak; Mary Marovich; Sheena McCormack; Sarah Joseph; Eligius Lyamuya; Britta Wahren; Eric Sandström; Gunnel Biberfeld; Michael Hoelscher; Muhammad Bakari; Arne Kroidl; Christof Geldmacher
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

2.  HIV control is mediated in part by CD8+ T-cell targeting of specific epitopes.

Authors:  Florencia Pereyra; David Heckerman; Jonathan M Carlson; Carl Kadie; Damien Z Soghoian; Daniel Karel; Ariel Goldenthal; Oliver B Davis; Charles E DeZiel; Tienho Lin; Jian Peng; Alicja Piechocka; Mary Carrington; Bruce D Walker
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

3.  Comparison of experimental fine-mapping to in silico prediction results of HIV-1 epitopes reveals ongoing need for mapping experiments.

Authors:  Julia Roider; Tim Meissner; Franziska Kraut; Thomas Vollbrecht; Renate Stirner; Johannes R Bogner; Rika Draenert
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

4.  Characterization of T-cell responses to cryptic epitopes in recipients of a noncodon-optimized HIV-1 vaccine.

Authors:  Anne Bet; Sarah Sterrett; Alicia Sato; Anju Bansal; Paul A Goepfert
Journal:  J Acquir Immune Defic Syndr       Date:  2014-02-01       Impact factor: 3.731

5.  Epitope mapping of HIV-specific CD8+ T cell responses by multiple immunological readouts reveals distinct specificities defined by function.

Authors:  Meika Richmond; Lyle R McKinnon; Sandra A Koesters Kiazyk; Charles Wachihi; Makobu Kimani; Joshua Kimani; Francis A Plummer; T Blake Ball
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

6.  Lytic and latent antigens of the human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus induce T-cell responses with similar functional properties and memory phenotypes.

Authors:  Florian Bihl; Murli Narayan; John V Chisholm; Leah M Henry; Todd J Suscovich; Elizabeth E Brown; Tania M Welzel; Daniel E Kaufmann; Tauheed M Zaman; Sheila Dollard; Jeff N Martin; Fred Wang; David T Scadden; Kenneth M Kaye; Christian Brander
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

7.  Enhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infection.

Authors:  Uma Malhotra; Fusheng Li; Jessica Nolin; Megan Allison; Hong Zhao; James I Mullins; Steve Self; M Juliana McElrath
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

8.  Peptide impurities in commercial synthetic peptides and their implications for vaccine trial assessment.

Authors:  Jeffrey R Currier; Lynee M Galley; Holger Wenschuh; Vivian Morafo; Silvia Ratto-Kim; Clive M Gray; Leonard Maboko; Michael Hoelscher; Mary A Marovich; Josephine H Cox
Journal:  Clin Vaccine Immunol       Date:  2007-12-12

9.  Increased cytotoxic T-lymphocyte epitope variant cross-recognition and functional avidity are associated with hepatitis C virus clearance.

Authors:  Daniel Yerly; David Heckerman; Todd M Allen; John V Chisholm; Kellie Faircloth; Caitlyn H Linde; Nicole Frahm; Joerg Timm; Werner J Pichler; Andreas Cerny; Christian Brander
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

10.  Tracking the culprit: HIV-1 evolution and immune selection revealed by single-genome amplification.

Authors:  Zabrina L Brumme; Bruce D Walker
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.